Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain

Naoki Tsuno(Shionogi (Japan)), Yasuyoshi Iso(Futaba (Japan)), Hiromi Nakai(Toyonaka Municipal Hospital), Miki Tanimura(Shionogi (Japan)), Satoko Funaki(Shionogi (Japan)), Mikie Hinata(Shionogi (Japan)), Shinji Suzuki(Tokyo Medical University), Natsue Yamanada(Shionogi (Japan)), Toshiyuki Kanemasa(Shionogi (Japan)), Gaku Sakaguchi(Shionogi (Japan)), Narumi Horita(Shionogi (Japan)), Azusa Nozu(Shionogi (Japan)), Kenji Takaya(Shionogi (Japan)), Yasuhide Morioka(Shionogi (Japan)), Hiroki Yamaguchi(National Heart Lung and Blood Institute), Masayuki Imai(Shionogi (Japan)), Akira Yukimasa(Shionogi (Japan)), Toshiyuki Asaki(University of Occupational and Environmental Health Japan), Masahiko Soga(Shionogi (Japan)), Osamu Yoshida(Ehime University Hospital), Tomoyuki Ogawa(Shionogi (Japan)), Hidetoshi Matsuda(Shionogi (Japan)), Motohiro Fujiu(University of California, Berkeley), Miyuki Yamamoto(The University of Tokyo), Daiki Nagamatsu(Shionogi (Japan))
Bioorganic & Medicinal Chemistry
March 1, 2017
Cited by 17


Related Papers